Regeneron Pharmaceuticals
REGN
#302
Rank
S$80.69 B
Marketcap
$738.13
Share price
2.53%
Change (1 day)
-39.38%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $50.37

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $48.97. In 2022 the company made an earnings per share (EPS) of $53.11 a decrease over its 2021 EPS that were of $100.20.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$50.37-5.16%
2022$53.11-47%
2021$100.20133.36%
2020$42.9469.13%
2019$25.39-14.44%
2018$29.67100.71%
2017$14.7831.78%
2016$11.2238.96%
2015$8.0772.55%
2014$4.68-17.55%
2013$5.68-44.98%
2012$10.32-422.54%
2011-$3.2092.13%
2010-$1.6649.41%
2009-$1.11-15.84%
2008-$1.32-36.88%
2007-$2.10-9.6%
2006-$2.324.12%
2005-$2.23-323.68%
2004$1.00-135.51%
2003-$2.80-24.38%
2002-$3.7156.35%
2001-$2.37187.3%
2000-$0.83-16%
1999-$0.98177.78%
1998-$0.35-35.71%
1997-$0.55-68.42%
1996-$1.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.55-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.39-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.20-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.46-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.90-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.17-91.49%๐Ÿ‡ซ๐Ÿ‡ท France